Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis.

Ormsby RT, Cantley M, Kogawa M, Solomon LB, Haynes DR, Findlay DM, Atkins GJ.

Acta Biomater. 2016 Mar 15;33:242-51. doi: 10.1016/j.actbio.2016.01.016. Epub 2016 Jan 18.

PMID:
26796208
2.

The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.

Algate K, Haynes DR, Bartold PM, Crotti TN, Cantley MD.

J Periodontal Res. 2015 Dec 15. doi: 10.1111/jre.12339. [Epub ahead of print] Review.

PMID:
26667183
3.

Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss.

Saad S, Dharmapatni AA, Crotti TN, Cantley MD, Algate K, Findlay DM, Atkins GJ, Haynes DR.

Acta Biomater. 2016 Jan 15;30:311-8. doi: 10.1016/j.actbio.2015.11.025. Epub 2015 Nov 18.

PMID:
26602825
4.

The X-Linked Inhibitor of Apoptosis Protein Inhibitor Embelin Suppresses Inflammation and Bone Erosion in Collagen Antibody Induced Arthritis Mice.

Dharmapatni AA, Cantley MD, Marino V, Perilli E, Crotti TN, Smith MD, Haynes DR.

Mediators Inflamm. 2015;2015:564042. doi: 10.1155/2015/564042. Epub 2015 Aug 4.

5.

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Crotti TN, Dharmapatni AA, Alias E, Haynes DR.

J Immunol Res. 2015;2015:281287. doi: 10.1155/2015/281287. Epub 2015 May 3. Review.

6.

Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue.

Cantley MD, Dharmapatni AA, Algate K, Crotti TN, Bartold PM, Haynes DR.

J Periodontal Res. 2016 Apr;51(2):143-51. doi: 10.1111/jre.12290. Epub 2015 Jun 2.

PMID:
26031835
7.

Parthenolide reduces empty lacunae and osteoclastic bone surface resorption induced by polyethylene particles in a murine calvarial model of peri-implant osteolysis.

Zawawi MS, Marino V, Perilli E, Cantley MD, Xu J, Purdue PE, Dharmapatni AA, Haynes DR, Crotti TN.

J Biomed Mater Res A. 2015 Nov;103(11):3572-9. doi: 10.1002/jbm.a.35484. Epub 2015 May 29.

PMID:
25903444
8.

Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis.

Cantley MD, Fairlie DP, Bartold PM, Marino V, Gupta PK, Haynes DR.

Rheumatology (Oxford). 2015 Sep;54(9):1713-23. doi: 10.1093/rheumatology/kev022. Epub 2015 Mar 31.

PMID:
25832610
9.

Caffeic acid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis.

Zawawi MS, Perilli E, Stansborough RL, Marino V, Cantley MD, Xu J, Dharmapatni AA, Haynes DR, Gibson RJ, Crotti TN.

Calcif Tissue Int. 2015 Jun;96(6):565-74. doi: 10.1007/s00223-015-9982-8. Epub 2015 Mar 25.

PMID:
25804981
10.

Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomography.

Perilli E, Cantley M, Marino V, Crotti TN, Smith MD, Haynes DR, Dharmapatni AA.

Scand J Immunol. 2015 Feb;81(2):142-50. doi: 10.1111/sji.12259.

11.

Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.

Howie DW, Neale SD, Haynes DR, Holubowycz OT, McGee MA, Solomon LB, Callary SA, Atkins GJ, Findlay DM.

Inflammopharmacology. 2013 Dec;21(6):389-96. doi: 10.1007/s10787-013-0192-6. Epub 2013 Oct 15. Review.

PMID:
24127125
12.

Effects of Osteochondrin S and select connective tissue ribonucleinate components on human osteoclasts in vitro.

Cantley MD, Rainsford KD, Haynes DR.

J Pharm Pharmacol. 2013 Aug;65(8):1214-22. doi: 10.1111/jphp.12088. Epub 2013 Jun 20.

PMID:
23837589
13.

Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA.

Rainsford KD, Haynes DR.

Inflammopharmacology. 2013 Aug;21(4):269-77. doi: 10.1007/s10787-013-0176-6. Epub 2013 Jul 4. Erratum in: Inflammopharmacology. 2013 Oct;21(5):387.

PMID:
23824627
14.

Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro.

Cantley MD, Rainsford KD, Haynes DR.

Inflammopharmacology. 2013 Dec;21(6):407-12. doi: 10.1007/s10787-013-0171-y. Epub 2013 May 4.

PMID:
23644893
15.

Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Bartold PM, du Bois AH, Gannon S, Haynes DR, Hirsch RS.

Inflammopharmacology. 2013 Aug;21(4):321-38. doi: 10.1007/s10787-012-0165-1. Epub 2013 Feb 28. Review.

PMID:
23446952
16.

Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.

Cantley MD, Haynes DR.

Inflammopharmacology. 2013 Aug;21(4):301-7. doi: 10.1007/s10787-012-0166-0. Epub 2013 Jan 23. Review.

PMID:
23341163
17.

The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.

Crotti TN, Dharmapatni AA, Alias E, Zannettino AC, Smith MD, Haynes DR.

Arthritis Res Ther. 2012 Nov 12;14(6):R245. doi: 10.1186/ar4088.

18.

Effect of Porphyromonas gingivalis on citrullination of proteins by macrophages in vitro.

Marchant C, Smith MD, Proudman S, Haynes DR, Bartold PM.

J Periodontol. 2013 Sep;84(9):1272-80. doi: 10.1902/jop.2012.120103. Epub 2012 Oct 29.

PMID:
23106505
19.

Azithromycin suppresses human osteoclast formation and activity in vitro.

Gannon SC, Cantley MD, Haynes DR, Hirsch R, Bartold PM.

J Cell Physiol. 2013 May;228(5):1098-107. doi: 10.1002/jcp.24259.

PMID:
23065774
20.

Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.

Zawawi MS, Dharmapatni AA, Cantley MD, McHugh KP, Haynes DR, Crotti TN.

Biochem Biophys Res Commun. 2012 Oct 19;427(2):404-9. doi: 10.1016/j.bbrc.2012.09.077. Epub 2012 Sep 20.

PMID:
23000414
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk